Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Reported Research Benefits Used in preclinical research focused on obesity, metabolic syndrome, diabetes, aging-related metabolic decline, fat mass reduction, and muscle preservation during caloric deficit
This reduces oral bioavailability from 2030% to an estimated 1218%
GI symptoms typically clear within one to two weeks of the last dose, roughly corresponding to the compound's elimination half-life
Ardawi, M.-S.M., et al., Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes
Optional but helpful: a peptide calculator helps you determine exact dosing based on your reconstitution volume
US$ 27.52
US$ 24.47
US$ 25.04
US$ 24.76
US$ 24.54
US$ 28.29
